Regulation of MDA5-MAVS Antiviral Signaling Axis by TRIM25 through TRAF6-Mediated NF-κB Activation

Na-Rae Lee1, Hye-In Kim1, Myung-Soo Choi1

  • 1Department of Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 130-701, Korea.

Molecules and Cells
|August 25, 2015
PubMed

Insights

Tripartite motif protein 25 (TRIM25) is essential for antiviral signaling by activating NF-κB. This protein plays a key role in RIG-I/MDA5 pathways beyond RIG-I ubiquitination, enhancing interferon production.

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • Tripartite motif protein 25 (TRIM25) is known to mediate K63-linked polyubiquitination of Retinoic acid inducible gene I (RIG-I), a critical step in antiviral interferon signaling.
  • RIG-I and melanoma differentiation-associated gene 5 (MDA5) are key sensors of viral RNA, initiating innate immune responses.

Purpose of the Study:

  • To investigate the role of TRIM25 in MDA5 and MAVS-mediated activation of NF-κB and interferon production.
  • To elucidate the specific mechanisms by which TRIM25 influences downstream signaling pathways.

Main Methods:

  • Western blotting to assess protein ubiquitination and activation.
  • Reporter assays to measure NF-κB and interferon promoter activity.
  • Immunofluorescence to track IRF3 nuclear translocation.

Main Results:

  • TRIM25 is demonstrated to be essential for MDA5 and MAVS-mediated activation of NF-κB and subsequent interferon production.
  • TRIM25 is required for the full activation of NF-κB downstream of MAVS, but not for IRF3 nuclear translocation.
  • Mechanical studies indicate TRIM25's involvement in TRAF6-mediated NF-κB activation.

Conclusions:

  • TRIM25 plays an additional, significant role in RIG-I/MDA5 signaling pathways beyond its known function in RIG-I ubiquitination.
  • TRIM25 contributes to innate antiviral immunity through the activation of NF-κB, independent of IRF3 activation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K